, Tracking Stock Market Picks
Enter Symbol:
Depomed, Inc. (DEPO) [hlAlert]

Sector Perform
up 93.59 %

Depomed, Inc. (DEPO) downgraded to Sector Perform with price target $32 by RBC Capital Mkts

Posted on: Thursday,  Jul 30, 2015  9:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Sector Perform Depomed, Inc. (NASDAQ: DEPO) on 07/30/2015. Previously RBC Capital Mkts rated Outperform Depomed, Inc. (NASDAQ: DEPO)
on 12/10/2014., when the stock price was $16.39. Since then, Depomed, Inc. has gained 93.59% as of 07/30/2015's recent price of $31.73.
If you would have followed the previous RBC Capital Mkts's recommendation on DEPO, you would have gained 93.59% of your investment in 232 days.

Depomed, Inc. (Depomed) is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies. Depomed has developed two commercial products: GLUMETZA (metformin hydrochloride extended release tablets), which is a once-daily treatment for adults with type 2 diabetes that it commercializes in the United States with Santarus, Inc. (Santarus). ProQuin XR (ciprofloxacin hydrochloride extended release tablets), which is a once-daily treatment for uncomplicated urinary tract infections that Depomed commercializes in the United States with Watson Pharma (Watson).

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/30/2015 9:25 AM Hold
31.73 32.00
as of 8/27/2015
1 Week   
1 Month up  37.47 %
3 Months up  58.49 %
1 YTD up  93.59 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/10/2014 8:25 AM Buy
16.39 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy